Skip to main content
. 2021 Oct;71(5):1–22. doi: 10.30802/AALAS-CM-20-000119

Table 2.

Summary of publications using cynomolgus macaque models of COVID-19.

Number, species,§, gender, age Virus strain, inoculation route†, (number exposed) Clinical signs, (dpi)* Gross and histologic lung pathology#, (dpi* euthanized) Viral detection‡, (dpi)* (Ref)
3 CM, 2 F/ 1 M, 10-15 y SARS-CoV-2 JP/TY/WK-521/2020, Combined IT, IN, PO 3/3 Fever 1-2 dpi, 1/3 10% weight loss, ↓ appetite, lymphopenia, neutrophilia All euthanized 28 dpi 3/3 Focal hemorrhage, interstitial pneumonia, 1/3 Congestion, thrombus, bronchopneumonia Nose, mouth, trachea conjunctiva, (1) 51
4 CM M/ F Adult (Sex ratio not listed) 2019-nCoV/USA-WA1/2020, Aerosol 4/4 Fever,↑respiratory sounds, 2/4 Tachypnea, ↑ respiratory effort, 3/ 4 Tachycardia Euthanized 18 dpi, 4/4 multifocal red to gray discoloration of one or more lung lobes, 1/4 Adhesions between pleura and thoracic wall, 3/4 DAD Nose, throat (3), Rectal swab (≥ 7) 53
8 CM 4M/ 4F, 3-6 y SARS-CoV-2 Korean isolate Combined IT, IN, PO, CJ, IV 4/8 Decreased activity and fever 8/8 Lymphopenia 4/8 (3 dpi): all had acute interstitial pneumonia, endotheliitis Nose, throat, rectum conjunctiva, (1) 58
6 CM 3 M/ 3 F 2-4 y SARS-CoV-2/ Victoria/01/2020 IT, IN None Euthanized: 2 NHP at 4/5 dpi, 14/15 dpi and 18/19 dpi Mild to moderate pulmonary consolidation Interstitial pneumonia, DAD Nose, throat (3), BALF (4-5), Rectum (1-9), 2/6 Whole blood (6) 96
6 CM 3 M/ 3 F, Adult SARS-CoV-2 from CDC, Guangdong Province China, Combined, IT, IN, CJ 4/6 Fever 5/6 Weight loss Pulmonary hemorrhage, ↑hilar and mediastinal lymphadenopathy, Interstitial pneumonia, diffuse hemorrhage and lung necrosis Nose, throat (2), Rectum, feces (2), 1/6 Rectum, feces (2- 21) 67
CM 8F, Half, 4-5 y, Half, 15-20 y SARS-CoV-2 German isolate Combined IT, IN No clinical signs 2 of each age group euthanized at 4 dpi, All had interstitial pneumonia, DAD Nose, throat: juvenilejuvenile (1-2), aged (4), 1/4 Rectum (14) 92

§ CM cynomolgus macaque, F female, M male, † intratracheal, IN intranasal, PO per oral, CJ conjunctival, IV intravenous, * dpi days postinfection, # DAD diffuse alveolar damage, ‡ BALF bronchoalveolar lavage fluid.